MY ACCOUNT | NEWSLETTER |

Diagnosis of intracardiac thrombosis in guinea pigs with cardiac disease


Cardiac disease is diagnosed with increased frequency in pet guinea pigs (Cavia porcellus) prompting the need for an improved understanding of disease-related sequelae. There are currently no reports describing intracardiac thrombosis associated with concurrent cardiac disease in guinea pigs.

Three guinea pigs were presented with varying degrees of dyspnea. Cardiomegaly and intracardiac thrombi were identified via echocardiogram or contrast-enhanced computed tomography. Two guinea pigs diagnosed with dilated cardiomyopathy were subsequently treated with varying combinations of cardiac therapeutic drugs. The third guinea pig was euthanized following imaging diagnosis and subsequently diagnosed with fibrinosuppurative myocarditis and endocarditis on post-mortem examination. On antemortem imaging and post-mortem examination, all three guinea pigs had left atrial thrombus present, and one guinea pig had concurrent left ventricular and caudal vena caval thrombi. All guinea pigs were euthanized 1–180 days after diagnosis due to congestive heart failure.

Intracardiac thrombosis may be an important consideration for guinea pigs in congestive heart failure. Contrast-enhanced computed tomography and/or echocardiogram are useful antemortem diagnostic tests which can direct appropriate medical management and prognosis determination. Further investigation of predispositions to intracardiac thrombosis and appropriate therapy in guinea pigs is needed.


“Diagnosis and post-mortem findings of intracardiac thrombosis in guinea pigs with cardiac disease: 3 cases (2020–2022)”. Chelsey Tournade, et al. Journal of Exotic Pet Medicine. Volume 49, April 2024, Pages 28-34.

Source: https://www.sciencedirect.com/science/article/pii/S1557506324000223


Cardiac disease is diagnosed with increased frequency in pet guinea pigs (Cavia porcellus) prompting the need for an improved understanding of disease-related sequelae. 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Ethical issues in geriatric feline medicine

Like0
Dislike0

The future of canine glaucoma therapy

Like0
Dislike0

Impact of antibiotic use in the swine industry

Like0
Dislike0

WSU researchers join $9.6M push to fight Rift Valley fever

Like0
Dislike0

PetPace™ Launches World's First AI Smart Collar that Includes 24/7 Global Telehealth and Telemedicine—Revolutionizing Real-Time Health Monitoring for Dogs and Cats

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top